Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Aevi Genomic Medicine Inc. is focused on genomic medicine. The Company focuses on translating genetic discoveries into novel therapies. Its product candidates include AEVI-001 and AEVI-002 which are in clinical trial stage. Aevi Genomic Medicine Inc., formerly known as Medgenics Inc., is based in WAYNE, United States.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -30,780 -34,710 -41,900 -37,990 -18,430
Net Income Growth +11.32% +17.16% -10.29% -106.13% -7.59%

Balance Sheet

(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Total Assets 12,280 34,760 40,560 54,260 34,280
Total Assets Growth -64.67% -14.30% -25.25% +58.28% +48.46%
Total Liabilities 4,350 4,140 5,580 3,910 4,620
Total Liabilities Growth +5.07% -25.81% +42.71% -15.37% -0.86%

Cash Flow

(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Operating Cash Flow -26,650 -33,250 -32,750 -24,350 -12,200
Operating Cash Flow Growth +19.85% -1.53% -34.50% -99.59% +4.16%
Net Cash Flow -21,650 -6,110 -13,230 19,780 10,900
Change in Net Cash Flow -254.34% +53.82% -166.89% +81.47% -31.70%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.